Diagnosis and Treatment of Bipolar Disorder: A Review
- PMID: 37815563
- DOI: 10.1001/jama.2023.18588
Diagnosis and Treatment of Bipolar Disorder: A Review
Abstract
Importance: Bipolar disorder affects approximately 8 million adults in the US and approximately 40 million individuals worldwide.
Observations: Bipolar disorder is characterized by recurrent episodes of depression and mania or hypomania. Bipolar depressive episodes are similar to major depressive episodes. Manic and hypomanic episodes are characterized by a distinct change in mood and behavior during discrete time periods. The age of onset is usually between 15 and 25 years, and depression is the most frequent initial presentation. Approximately 75% of symptomatic time consists of depressive episodes or symptoms. Early diagnosis and treatment are associated with a more favorable prognosis. Diagnosis and optimal treatment are often delayed by a mean of approximately 9 years following an initial depressive episode. Long-term treatment consists of mood stabilizers, such as lithium, valproate, and lamotrigine. Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associated with weight gain. Antidepressants are not recommended as monotherapy. More than 50% of patients with bipolar disorder are not adherent to treatment. Life expectancy is reduced by approximately 12 to 14 years in people with bipolar disorder, with a 1.6-fold to 2-fold increase in cardiovascular mortality occurring a mean of 17 years earlier compared with the general population. Prevalence rates of metabolic syndrome (37%), obesity (21%), cigarette smoking (45%), and type 2 diabetes (14%) are higher among people with bipolar disorder, contributing to the risk of early mortality. The annual suicide rate is approximately 0.9% among individuals with bipolar disorder, compared with 0.014% in the general population. Approximately 15% to 20% of people with bipolar disorder die by suicide.
Conclusions and relevance: Bipolar disorder affects approximately 8 million adults in the US. First-line therapy includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, and atypical antipsychotic drugs, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine.
Similar articles
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18. Encephale. 2017. PMID: 27871720 Review. French.
-
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.Mol Psychiatry. 2021 Aug;26(8):4146-4157. doi: 10.1038/s41380-020-00946-6. Epub 2020 Nov 11. Mol Psychiatry. 2021. PMID: 33177610 Free PMC article.
-
[Mood Stabilizers: An Overview].Brain Nerve. 2023 May;75(5):605-611. doi: 10.11477/mf.1416202386. Brain Nerve. 2023. PMID: 37194539 Japanese.
-
[Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].Encephale. 2014 Sep;40(4):330-7. doi: 10.1016/j.encep.2013.10.007. Epub 2014 Feb 7. Encephale. 2014. PMID: 24513018 Review. French.
Cited by
-
Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes.Pharmaceuticals (Basel). 2024 May 16;17(5):642. doi: 10.3390/ph17050642. Pharmaceuticals (Basel). 2024. PMID: 38794212 Free PMC article. Review.
-
Latent Profile Analysis of Suicidal Ideation in Chinese Individuals with Bipolar Disorder.Behav Sci (Basel). 2024 Apr 25;14(5):360. doi: 10.3390/bs14050360. Behav Sci (Basel). 2024. PMID: 38785851 Free PMC article.
-
Integrated proteomic and genomic analysis to identify predictive biomarkers for valproate response in bipolar disorder: a 6-month follow-up study.Int J Bipolar Disord. 2024 May 17;12(1):19. doi: 10.1186/s40345-024-00342-x. Int J Bipolar Disord. 2024. PMID: 38758284 Free PMC article.
-
Nutraceuticals in Psychiatric Disorders: A Systematic Review.Int J Mol Sci. 2024 Apr 28;25(9):4824. doi: 10.3390/ijms25094824. Int J Mol Sci. 2024. PMID: 38732043 Free PMC article.
-
Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder.BMC Psychiatry. 2024 May 10;24(1):352. doi: 10.1186/s12888-024-05810-3. BMC Psychiatry. 2024. PMID: 38730288 Free PMC article.